KPower Stock

Equities

RENEUCO

MYL7130OO007

Construction & Engineering

End-of-day quote BURSA MALAYSIA 06:00:00 2024-04-22 pm EDT 5-day change 1st Jan Change
0.095 MYR +5.56% Intraday chart for KPower +26.67% -56.82%
Sales 2022 140M 29.38M Sales 2023 51.68M 10.81M Capitalization 128M 26.76M
Net income 2022 5M 1.05M Net income 2023 -93M -19.46M EV / Sales 2022 0.85 x
Net cash position 2022 320K 66.97K Net Debt 2023 85.74M 17.94M EV / Sales 2023 4.13 x
P/E ratio 2022
19.2 x
P/E ratio 2023
-1.25 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 67.22%
More Fundamentals * Assessed data
Dynamic Chart
Reneuco Berhad Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Citaglobal-Reneuco Consortium Secure MYR600 Million ECRL Deal MT
Citaglobal Reneuco Energy Solution Sdn Bhd Announces Acceptance of Conditional Letter of Award from MRL CI
Reneuco, Aliran Technologies to Undertake Project for Malaysia's Ministry of Rural and Regional Development MT
Reneuco, Zamil Steel Buildings Vietnam to Explore Opportunities MT
Reneuco Berhad Announces Appointment of Dato' Dr Md Khir Bin Abdul Rahman as Independent and Non Executive Member of Risk Committee CI
Reneuco Berhad Announces Redesignation of Datuk Ir Ts. Dr. Muhammad Mahadi Bin Mohamad from Independent and Non Executive Chairman of Risk Committee to Independent and Non Executive Member of Risk Committee CI
Reneuco Berhad Announces Redesignation of Tan Yee Hou from Independent and Non Executive Member of Risk Committee to Independent and Non Executive Chairman of Risk Committee CI
Reneuco Berhad Announces Redesignation of Tan Yee Hou from Independent and Non Executive Member of Remuneration Committee to Independent and Non Executive Chairman of Remuneration Committee CI
Reneuco Berhad Announces Appointment of Datuk Ir Ts. Dr. Muhammad Mahadi Bin Mohamad as Independent and Non Executive Member of Remuneration Committee CI
Reneuco Berhad Announces Redesignation of Cik Sarah Azreen Binti Abdul Samat from Executive Chairman of Remuneration Committee to Executive Member of Remuneration Committee CI
Reneuco Berhad Announces Redesignation of Datuk Ir Ts. Dr. Muhammad Mahadi Bin Mohamad from Independent and Non Executive Member of Nomination Committee to Independent and Non Executive Chairman of Nomination Committee CI
Reneuco Berhad Announces Resignation of Cik Sarah Azreen Binti Abdul Samat as Executive Chairman of Nomination Committee CI
Reneuco Berhad Announces Redesignation of Cik Sarah Azreen Binti Abdul Samat from Deputy Chairman to Executive Director CI
Reneuco Berhad Announces Appointment of Tan Yee Hou as Independent and Non Executive Member of Audit Committee CI
More news
1 day+20.00%
1 week+20.00%
Current month+28.57%
1 month+20.00%
3 months-47.06%
6 months-52.63%
Current year-59.09%
More quotes
1 week
0.07
Extreme 0.065
0.10
1 month
0.07
Extreme 0.065
0.10
Current year
0.04
Extreme 0.035
0.24
1 year
0.04
Extreme 0.035
0.28
3 years
0.04
Extreme 0.035
2.14
5 years
0.04
Extreme 0.035
2.91
10 years
0.04
Extreme 0.035
2.91
More quotes
Managers TitleAgeSince
Chief Executive Officer 47 19-06-30
Director of Finance/CFO 46 21-03-31
Chairman 51 19-06-27
Members of the board TitleAgeSince
Director/Board Member - 23-09-17
Director/Board Member 60 23-09-17
Director/Board Member 41 19-03-12
More insiders
Date Price Change Volume
24-04-22 0.095 +5.56% 35 052 000
24-04-22 0.09 +20.00% 60,148,700
24-04-19 0.075 +7.14% 15,957,800
24-04-18 0.07 -6.67% 1,658,900
24-04-17 0.075 0.00% 651,000

End-of-day quote BURSA MALAYSIA, April 21, 2024

More quotes
Reneuco Berhad is a Malaysia-based company involved in sustainable energy and utilities activities. The Company's segments include Construction related activities, Logistics, Property development and investment, and Healthcare. The Construction related activities segment includes engineering, procurement, construction and commissioning of energy utilities and infrastructure projects and investment holding. The Logistics segment provides transportation and forwarding services. It provides logistics solutions to various multinational companies for chemical and gas. The Property development and investment segment is engaged in the development and construction of commercial properties, and investment in land and buildings that are held for long term rental yields and/or capital appreciation. The Healthcare segment is engaged in the manufacturing, distribution and trading of healthcare related products. It manufactures synthetic bone graft, bone cement and also supply Covid-19 equipment.
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RENEUCO Stock